Commentary: Endometriosis - Epidemiologic considerations for a potentially 'high-risk' population

International Journal of Epidemiology

Volumn 38, Issue 4, 2009, Pages 1154-1155

  Missmer, Stacey A ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNE DISEASE; CANCER RISK; CAUCASIAN; DISEASE ASSOCIATION; ENDOMETRIOSIS; FEMALE; FIBRINOLYSIS; GENETIC VARIABILITY; HAPLOTYPE; HIGH RISK POPULATION; HUMAN; HYSTERECTOMY; LAPAROSCOPY; MELANOMA; MORBIDITY; NOTE; PREVALENCE; PRIORITY JOURNAL; VASCULITIS;

ENDOMETRIOSIS; FEMALE; HUMANS; MELANOSIS; NEVUS, PIGMENTED; PHOTOSENSITIVITY DISORDERS; SKIN NEOPLASMS;

EID: 68849085865     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyp249     Document Type: Note

References (17)

1. Jones GL, Kennedy SH, Jenkinson C. Health-related quality of life measurement in women with common benign gynecologic conditions: A systematic review. Am J Obstet Gynecol 2002;187:501-11.
2. Kjerulff KH, Erickson BA, Langenberg PW. Chronic gynecological conditions reported by US women: Findings from the National Health Interview Survey, 1984 to 1992. Am J Public Health 1996;86 195-99.
3. Simoens S, Hummelshoj L, D'Hooghe T. Endometriosis: Cost estimates and methodological perspective. Hum Reprod Update 2007;13 395-404.
4. Missmer SA, Cramer DW. The epidemiology of endometriosis. Obstet Gynecol Clin North Am 2003;30:1-19, vii.
5. Badawy SZ, Cuenca V, Stitzel A, Jacobs RD, Tomar RH. Autoimmune phenomena in infertile patients with endometriosis. Obstet Gynecol 1984;63:271-75.
6. Sinaii N, Cleary SD, Ballweg ML, Nieman LK, Stratton P. High rates of autoimmune and endocrine disorders, fibromyalgia, chronic fatigue syndrome and atopic diseases among women with endometriosis: A survey analysis. Hum Reprod 2002;17:2715-24.
7. Mahnke JL, Dawood MY, Huang JC. Vascular endothelial growth factor and interleukin-6 in peritoneal fluid of women with endometriosis. Fertil Steril 2000;73:166-70.
8. Bedaiwy MA, Falcone T, Mascha EJ, Casper RF. Genetic polymorphism in the fibrinolytic system and endometriosis. Obstet Gynecol 2006;108 162-68.
9. Brinton LA, Gridley G, Persson I, Baron J, Bergqvist A. Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol 1997;176:572-79.
10. Ness RB, Modugno F. Endometriosis as a model for inflammation-hormone interactions in ovarian and breast cancers. Eur J Cancer 2006; 42:691-703.
11. Kvaskoff M, Mesrine S, Clavel-Chapelon F, Boutron-Ruault MC. Endometriosis risk in relation to naevi, freckles and skin sensitivity to sun exposure: The French E3N cohort. Int J Epidemiol 2009;38 1143-53.
12. Kvaskoff M, Mesrine S, Fournier A, Boutron-Ruault MC, Clavel-Chapelon F. Personal history of endometriosis and risk of cutaneous melanoma in a large prospective cohort of French women. Arch Intern Med 2007; 167: 2061-65.
13. Montgomery GW, Nyholt DR, Zhao ZZ et al. The search for genes contributing to endometriosis risk. Hum Reprod Update 2008;14 447-57.
14. Olson JE, Cerhan JR, Janney CA, Anderson KE, Vachon CM, Sellers TA. Postmenopausal cancer risk after self-reported endometriosis diagnosis in the Iowa Women's Health Study. Cancer 2002;94:1612-18.
15. Templeman C, Marshall SF, Ursin G et al. Adenomyosis and endometriosis in the California Teachers Study. Fertil Steril 2008;90:415-24.
16. Missmer SA, Hankinson SE, Spiegelman D, Barbieri RL, Marshall LM, Hunter DJ. Incidence of laparoscopically confirmed endometriosis by demographic, anthropometric, and lifestyle factors. Am J Epidemiol 2004;160: 784-96.
17. Zondervan KT, Cardon LR, Kennedy SH. What makes a good case-control study? Design issues for complex traits such as endometriosis. Hum Reprod 2002;17:1415-23.